PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
05-Feb-2024 seqWell Announces LongPlex Product to Address Multiplexing Challenges in Long Read Library Prep Businesswire
05-Feb-2024 Global Single Use Assemblies Market Analysis and Forecast 2024-2033, Featuring Avantor, Merck, Thermo Fisher Scientific, Saint-Gobain & Parker Hannifin - ResearchAndMarkets.com Businesswire
05-Feb-2024 biomodal Delivers the 6-Base Genome with a Powerful New Multiomic Solution, duet evoC Businesswire
05-Feb-2024 biomodal liefert das 6-Basen-Genom mit einer leistungsstarken neuen Multiomics-Lösung: duet evoC Businesswire
05-Feb-2024 biomodal apporte le génome à 6 bases grâce à duet evoC, sa nouvelle solution multiomique Businesswire
05-Feb-2024 Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple Myeloma Based on KarMMa-3 Study Businesswire
05-Feb-2024 Merck Animal Health to Acquire Elanco’s Aqua Business Businesswire
05-Feb-2024 Iodine Software Introduces AwareUM, a New Solution That Helps Hospitals Streamline Utilization Management and Strengthen Revenue Integrity AccessWire
05-Feb-2024 Bristol Myers Squibb Named One of America’s Most JUST Companies by JUST Capital and CNBC AccessWire
05-Feb-2024 Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms AccessWire
05-Feb-2024 MentalHealth.com Appoints Co-Founder Jeff Smith to Venture Advisory Team and Digital Operations AccessWire
05-Feb-2024 Clarity Clinic Earns Prestigious Accreditation From the Joint Commission AccessWire
05-Feb-2024 CLS Health Empowers Physicians with Operational Support AccessWire
05-Feb-2024 Vektor Medical Secures $16 Million Series A Funding Businesswire
05-Feb-2024 ARRALYZE(R) Launches CellShepherd(R): A Fully Autonomous Single-Cell Platform For Real-Time Monitoring Of Functional Assays AccessWire
05-Feb-2024 Tharimmune Announces Dosing of First Patient in Phase 1 Clinical Trial of TH104, its Lead Candidate for Pruritus in Primary Biliary Cholangitis AccessWire
05-Feb-2024 WallabyPhenox Boldly Sets New Benchmark in Evidence-Based Medicine With the PROST Trial AccessWire
05-Feb-2024 MPH Health Care AG sells 1.5 million shares in its investment M1 Kliniken AG to its Management Board members MPH Health Care AG
05-Feb-2024 Management Board of M1 Kliniken AG acquires 1.5 million shares in the company and plans an uplisting to the Prime Standard M1 Kliniken AG
05-Feb-2024 Toku Obtains CE and UKCA Marks for AI Cardiovascular Risk Assessments Through the Eye Businesswire